Analysis of clinical outcomes according to original treatment groups 16 years after the pivotal IFNB-1b trial.

Ebers GC, Traboulsee A, Li D, Langdon D, Reder AT, Goodin DS, Bogumil T, Beckmann K, Wolf C, Konieczny A, et al.